ArticlePloS one2025
An interpretable machine learning model for predicting in-hospital mortality in ICU patients with ventilator-associated pneumonia.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Development and validation of a predictive nomogram for ventilator-associated pneumonia in patients with traumatic brain injury: based on the MIMIC-IV database.Journal of thoracic disease · 2026Article
- Large-scale automated phenotyping of cardiac arrest and withdrawal of life-sustaining therapy using electronic health record data.Resuscitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVentilator-associated pneumonia (VAP) is a common nosocomial infection in ICU, significantly associated with poor outcomes. However, there is currently a lack of reliable and interpretable tools for assessing the risk of in-hospital mortality in VAP patients. This study aims to develop an interpretable machine learning (ML) prediction model to enhance the assessment of in-hospital mortality risk in VAP patients.
methodsThis study extracted VAP patient data from versions 2.2 and 3.1 of the MIMIC-IV database, using version 2.2 for model training and validation, and version 3.1 for external testing. Feature selection was conducted using the Boruta algorithm, and 14 ML models were constructed. The optimal model was identified based on the area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, and specificity across both validation and test cohorts. SHapley Additive exPlanations (SHAP) analysis was applied for global and local interpretability.
resultsA total of 1,894 VAP patients were included, with 12 features ultimately selected for model construction: 24-hour urine output, blood urea nitrogen, age, diastolic blood pressure, platelet count, anion gap, body temperature, bicarbonate level, sodium level, body mass index, and whether combined with congestive heart failure and cerebrovascular disease. The random forest (RF) model showed the best performance, achieving an AUC of 0.780 in internal validation and 0.724 in external testing, outperforming other ML models and common clinical scoring systems.
conclusionThe RF model demonstrated robust and reliable performance in predicting in-hospital mortality risk for VAP patients. The developed online tool can assist clinicians in efficiently assessing VAP in-hospital mortality risk, supporting clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.